Abbott India
ABBOTINDIA · Pharma > Pharmaceuticals & Drugs · Chairman: Munir Shaikh Listing date: Jan. 9, 2010 · Employees: 3585 · Mumbai · http://www.abbott.co.in

Stock Price vs Company Growth
1d
1.2%
1w
2.1%
1m
7.9%
3m
1.1%
6m
2.6%
1y
15.4%
5y
6.7%
10y
20.3%
all
24.6%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 25,598 1.2%
24,620
28,582
Company Overview

Sales
7,004 Cr
Growth: 7.5%
Profit after Tax
1,615 Cr
Growth: 4.0%
Large Cap
54,395 Cr
P/E: 33.7x
Industry P/E: 34.2x
Fundamentals

Sales (Cr) ₹ 7,004
Growth 7.5%
EBITDA 28.1%
P/S 7.8x
Dividend 1.4%
P/E 33.7x
Book Value ₹ 2,448
PEG Ratio 4.6x
ROE 31.7%
P/B 10.6x
Shareholding Pattern

Institutions
Life Insurance Corporation Of India
1.64 %
Promoters
Abbott Capital India Limited
50.44 %
Abbott Healthcare Products Limited
17.62 %
British Colloids Limited
6.92 %
Others
Increase    Decrease    No change
Company Profile Detailed

The company is one of the leading multinational pharmaceutical companies in India and operates with owned manufacturing units and various independent contract/third party manufacturers based across the country. The company sells its products through independent distributors primarily within India.
Investors (50)
Followers (16)